IMNM Scorecard | Immunome, Inc.

Immunome, Inc. (IMNM) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

20/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseIMNM / S&P -3.11% / 15.20%	LoseIMNM / S&P -100.00% / 15.00%	LoseIMNM / S&P -17.86% / 50.40%
2026-Q11/3	WinIMNM / S&P 1.82% / -4.33%	LoseIMNM / S&P -63.29% / 11.30%	LoseIMNM / S&P -25.16% / 27.70%
2025-Q41/3	WinIMNM / S&P 83.43% / 2.65%	LoseIMNM / S&P -23.23% / 9.00%	LoseIMNM / S&P -53.19% / 13.40%
2025-Q31/3	WinIMNM / S&P 25.91% / 8.12%	LoseIMNM / S&P -4.44% / 4.61%	LoseIMNM / S&P -63.63% / 13.45%
2025-Q22/3	WinIMNM / S&P 38.19% / 10.94%	WinIMNM / S&P 16.74% / 4.83%	LoseIMNM / S&P -59.95% / 10.63%
2025-Q10/3	LoseIMNM / S&P -36.63% / -4.27%	LoseIMNM / S&P -13.76% / 4.98%	LoseIMNM / S&P -57.88% / 10.57%
2024-Q40/3	LoseIMNM / S&P -27.36% / 2.41%	LoseIMNM / S&P -35.50% / 5.25%	LoseIMNM / S&P -4.08% / 6.15%
2024-Q32/3	WinIMNM / S&P 20.83% / 5.89%	LoseIMNM / S&P IMNM unavailable / 5.89%	WinIMNM / S&P 348.07% / 6.11%
2024-Q21/3	LoseIMNM / S&P -50.97% / 4.28%	LoseIMNM / S&P IMNM unavailable / 5.38%	WinIMNM / S&P 249.55% / 5.12%
2024-Q12/3	WinIMNM / S&P 130.65% / 10.56%	LoseIMNM / S&P IMNM unavailable / 5.71%	WinIMNM / S&P 204.44% / 5.59%
2023-Q42/3	WinIMNM / S&P 28.14% / 11.69%	LoseIMNM / S&P IMNM unavailable / 6.81%	WinIMNM / S&P 74.43% / 7.78%
2023-Q31/3	WinIMNM / S&P 5.56% / -3.27%	LoseIMNM / S&P IMNM unavailable / 7.52%	LoseIMNM / S&P -41.61% / -5.03%
2023-Q21/3	WinIMNM / S&P 58.52% / 8.74%	LoseIMNM / S&P IMNM unavailable / 9.50%	LoseIMNM / S&P -26.67% / -8.57%
2023-Q12/3	WinIMNM / S&P 125.79% / 7.50%	LoseIMNM / S&P IMNM unavailable / 10.77%	WinIMNM / S&P -8.82% / -15.69%
2022-Q41/3	LoseIMNM / S&P -50.23% / 7.56%	LoseIMNM / S&P IMNM unavailable / 11.88%	WinIMNM / S&P 45.07% / -17.99%
2022-Q31/3	WinIMNM / S&P 38.32% / -4.88%	LoseIMNM / S&P IMNM unavailable / 13.47%	LoseIMNM / S&P IMNM unavailable / -1.41%
2022-Q20/3	LoseIMNM / S&P -43.49% / -16.10%	LoseIMNM / S&P IMNM unavailable / 13.71%	LoseIMNM / S&P IMNM unavailable / 11.04%
2022-Q10/3	LoseIMNM / S&P -56.17% / -4.60%	LoseIMNM / S&P IMNM unavailable / 15.97%	LoseIMNM / S&P IMNM unavailable / 42.23%
2021-Q40/3	LoseIMNM / S&P -46.78% / 11.03%	LoseIMNM / S&P IMNM unavailable / 15.00%	LoseIMNM / S&P IMNM unavailable / 96.40%
2021-Q31/3	WinIMNM / S&P 40.75% / 0.58%	LoseIMNM / S&P IMNM unavailable / 10.77%	LoseIMNM / S&P IMNM unavailable / 69.42%
2021-Q20/3	LoseIMNM / S&P -48.94% / 8.55%	LoseIMNM / S&P IMNM unavailable / 6.58%	LoseIMNM / S&P IMNM unavailable / 51.81%
2021-Q11/3	WinIMNM / S&P 250.00% / 6.17%	LoseIMNM / S&P IMNM unavailable / -1.06%	LoseIMNM / S&P IMNM unavailable / 7.39%
2020-Q40/3	LoseIMNM / S&P IMNM unavailable / 12.15%	LoseIMNM / S&P IMNM unavailable / -3.72%	LoseIMNM / S&P IMNM unavailable / -33.42%
2020-Q30/3	LoseIMNM / S&P IMNM unavailable / 8.93%	LoseIMNM / S&P IMNM unavailable / -2.04%	LoseIMNM / S&P IMNM unavailable / -27.10%
2020-Q20/3	LoseIMNM / S&P IMNM unavailable / 20.54%	LoseIMNM / S&P IMNM unavailable / -0.46%	LoseIMNM / S&P IMNM unavailable / -27.11%
2020-Q10/3	LoseIMNM / S&P IMNM unavailable / -19.60%	LoseIMNM / S&P IMNM unavailable / 3.47%	LoseIMNM / S&P IMNM unavailable / -14.75%
2019-Q40/3	LoseIMNM / S&P IMNM unavailable / 9.07%	LoseIMNM / S&P IMNM unavailable / 5.36%	LoseIMNM / S&P IMNM unavailable / 2.99%
2019-Q30/3	LoseIMNM / S&P IMNM unavailable / 1.70%	LoseIMNM / S&P IMNM unavailable / 5.02%	LoseIMNM / S&P IMNM unavailable / 0.21%
2019-Q20/3	LoseIMNM / S&P IMNM unavailable / 4.30%	LoseIMNM / S&P IMNM unavailable / 6.64%	LoseIMNM / S&P IMNM unavailable / 8.65%
2019-Q10/3	LoseIMNM / S&P IMNM unavailable / 13.65%	LoseIMNM / S&P IMNM unavailable / 8.12%	LoseIMNM / S&P IMNM unavailable / 14.29%
2018-Q40/3	LoseIMNM / S&P IMNM unavailable / -13.52%	LoseIMNM / S&P IMNM unavailable / 9.05%	LoseIMNM / S&P IMNM unavailable / 18.23%
2018-Q30/3	LoseIMNM / S&P IMNM unavailable / 7.71%	LoseIMNM / S&P IMNM unavailable / 10.21%	LoseIMNM / S&P IMNM unavailable / 19.06%
2018-Q20/3	LoseIMNM / S&P IMNM unavailable / 3.43%	LoseIMNM / S&P IMNM unavailable / 9.03%	LoseIMNM / S&P IMNM unavailable / 14.46%
2018-Q10/3	LoseIMNM / S&P IMNM unavailable / -0.76%	LoseIMNM / S&P IMNM unavailable / 7.68%	LoseIMNM / S&P IMNM unavailable / 12.46%
2017-Q40/3	LoseIMNM / S&P IMNM unavailable / 6.64%	LoseIMNM / S&P IMNM unavailable / 7.03%	LoseIMNM / S&P IMNM unavailable / 13.82%
2017-Q30/3	LoseIMNM / S&P IMNM unavailable / 4.48%	LoseIMNM / S&P IMNM unavailable / 5.68%	LoseIMNM / S&P IMNM unavailable / 17.57%
2017-Q20/3	LoseIMNM / S&P IMNM unavailable / 3.09%	LoseIMNM / S&P IMNM unavailable / 4.83%	LoseIMNM / S&P IMNM unavailable / 17.74%
2017-Q10/3	LoseIMNM / S&P IMNM unavailable / 6.07%	LoseIMNM / S&P IMNM unavailable / 3.67%	LoseIMNM / S&P IMNM unavailable / 13.32%
2016-Q40/3	LoseIMNM / S&P IMNM unavailable / 3.82%	LoseIMNM / S&P IMNM unavailable / 2.09%	LoseIMNM / S&P IMNM unavailable / 7.05%
2016-Q30/3	LoseIMNM / S&P IMNM unavailable / 3.85%	LoseIMNM / S&P IMNM unavailable / 0.20%	LoseIMNM / S&P IMNM unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	IMNM total return	S&P 500 Total Return Index
Total return	203.58%	20.78%
Annualized return	203.58%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	IMNM total return	S&P 500 Total Return Index
Total return	93.24%	83.14%
Annualized return	14.08%	12.86%

10Y · 2020-10-02 to 2026-08-27

Metric	IMNM total return	S&P 500 Total Return Index
Total return	114.65%	319.30%
Annualized return	7.94%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40
SUPERNUS PHARMACEUTICALS, INC. (SUPN)	United States	$2.517B	-24.63
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
SELLAS Life Sciences Group, Inc. (SLS)	United States	$2.420B	-91.87
uniQure N.V. (QURE)		$2.416B	-4.93
MBX Biosciences, Inc. (MBX)	United States	$2.664B	-25.36
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67
NewAmsterdam Pharma Co N.V. (NAMS)		$2.719B	-15.37
Mineralys Therapeutics, Inc. (MLYS)	United States	$2.353B	-6.82